Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Success
Alert
Please select a Day.
Info

Bal Pharma Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

30/100
71.64
-0.80 (-1.10%)

As on 31 Dec, 2025 | 11:19

Open Trading A/c
Day Range
71.06
73.80
L H
52 Week Range
69.00
132.00
L H
Volume
2,673
*
i

* BSE Market Depth (31 Dec 2025)

BUY SELL
QTY PRICE PRICE QTY
2 71.20 72.39 18
526 71.18 72.40 1528
1 71.15 72.53 50
2 71.10 72.60 65
65 71.01 72.65 65
15854 Total Total 3590
Bid / Ask
71.20 / 72.39
30/100
72.00
-0.60 (-0.83%)

As on 31 Dec, 2025 | 11:19

Open Trading A/c
Day Range
72.00
72.40
L H
52 Week Range
67.15
131.45
L H
Volume
664
*
i

* BSE Market Depth (31 Dec 2025)

BUY SELL
QTY PRICE PRICE QTY
2 71.20 72.39 18
526 71.18 72.40 1528
1 71.15 72.53 50
2 71.10 72.60 65
65 71.01 72.65 65
15854 Total Total 3590
Bid / Ask
71.20 / 72.39
NSE
MC Essentials
47% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Low Financial Strength, Low Growth Trend Stock at Discounted Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 72.44
          Previous Close 72.44
          Volume 2,673.00
          Value (Lacs) 1.91
            VWAP 71.84
          Beta
          Mkt Cap (Rs. Cr.) 114
          High 73.80
          Low 71.06
          UC Limit 86.92
          LC Limit 57.96
          52 Week High 132.00
          52 Week Low 69.00
          Face Value 10.00
          All Time High 167.90
          All Time Low 13.00
          20D Avg Volume 6,938
          20D Avg Delivery(%) 65.95
          Book Value Per Share 49.20
          Dividend Yield 1.68
          TTM EPS See historical trend 4.29 (-10.85% YoY)
          TTM PE See historical trend 16.70 (Low PE)
          P/B See historical trend 1.46 (Low P/B)
          Sector PE 39.46

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          30/100
          Low Financial Strength, Low Growth Trend Stock at Discounted Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 45.73% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 50.86% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          9 out of 17 years Bal Pharma has given negative returns in December.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          December 17.83% (2017) 7.62% -17.11% (2014) -7.33% -0.30%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Bal Pharma

          What's your call on Bal Pharma today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          04 Apr, 2025

          Nk Securities Research Private Limited

          Qty 132023 Price 121.17 % Traded 0.82
          04 Apr, 2025

          Nk Securities Research Private Limited

          Qty 132023 Price 121.03 % Traded 0.82
          04 Apr, 2025

          Mudupulavemula Surendranadha Reddy

          Qty 123412 Price 121.51 % Traded 0.77
          04 Apr, 2025

          Mudupulavemula Surendranadha Reddy

          Qty 123412 Price 120.96 % Traded 0.77
          04 Apr, 2025

          Parth Infin Brokers Pvt Ltd

          Qty 110803 Price 124.36 % Traded 0.71
          04 Apr, 2025

          Parth Infin Brokers Pvt Ltd

          Qty 110803 Price 125.31 % Traded 0.71

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          About the Company

          Bal Pharma Ltd is engaged in the manufacturing of API, finished formulations, ayurvedic and research and development. They are one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives. The company offers products for treatment of diabetes, cardiometabolics, gynaecology, dermatology, gastroenterology, orthopaedics, ENT and multi-speciality segments.They also produce a range of APIs that includes Anti Histamine, Platelet inhibitor, Antidiabetic, Anti Convulsant, urinary incontinence, Neuropathic pain, Anti allergy, Anti inflammatory, Diuretic, Acne Treatment etc.Their R&D unit is also engaged in developing processes for novel bulk actives (active pharmaceutical ingredients, APIs) and new chemical substances for therapeutic applications.
          {"success":1,"data":{"address":{"address1":"# 21 & 22,","address2":",","city":"Bengaluru","state":"Karnataka","pincode":"560099","telephone1":"080-22354057","telephone2":"","fax1":"080-41570820","fax2":"","email":"info@balpharma.com","web":"http:\/\/www.balpharma.com"},"management":[{"name":"Shailesh D Siroya","designation":"Managing Director"},{"name":"Himesh Virupakshaya","designation":"Executive Director"},{"name":"Ravindrakumar Kothari","designation":"Non Executive Director"},{"name":"Jatish Sheth","designation":"Independent Director"},{"name":"Nicloa Neeladri","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524824","nseId":"BALPHARMA","series":"EQ","isinid":"INE083D01012"}}}
          • Registered Office

          • Registrars

          • Management

            • Shailesh D Siroya

              Managing Director

            • Himesh Virupakshaya

              Executive Director

            • Ravindrakumar Kothari

              Non Executive Director

            • Jatish Sheth

              Independent Director

            • Nicloa Neeladri

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              524824

            • NSE:

              BALPHARMA

            • Series

              EQ

            • ISIN

              INE083D01012

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347